Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

5.90
BATS BZX Real-Time Price
As of 3:59pm ET
 +0.09 / +1.55%
Today’s Change
2.80
Today|||52-Week Range
10.80
+16.83%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$614.8M

Company Description

Keryx Biopharmaceuticals, Inc. engages in the development and commercialization of medicines for the treatment of renal disease. Its products include phosphate-binding medicines, intravenous iron, and other medications. The company was founded in October 1998 and is headquartered in Boston, MA.

Contact Information

Keryx Biopharmaceuticals, Inc.
12th Floor
Boston Massachusetts 02210
P:(617) 466-3500
Investor Relations:
(617) 466-3511

Employees

Shareholders

Other institutional42.39%
Mutual fund holders22.50%
Individual stakeholders14.61%

Top Executives

Gregory P. MadisonChief Executive Officer & Director
Scott A. HolmesChief Financial Officer
John F. NeylanChief Medical Officer
Daniel W. OlmsteadVice President-Payer Access
Lora L. PikeSenior Director-Investor Relations